ÂÜÀòÂÒÂ×

Dr. Haque is a General Medicine physician with over 17 years of pharmaceutical industry experience. He held leadership roles across various phases of drug development and drug safety-pharmacovigilance within both large and small pharmaceutical companies, such as Wyeth, Pfizer, Abbott, Alexion, Baxalta/Shire and Insmed. His work encompassed successful IND, NDA, BLA, global approvals and launch with postmarketing continuation of therapies in Oncology, Endocrine, Inflammatory, Infectious Diseases and various Rare diseases. Dr. Haque received his medical degree at Burdwan University in West Bengal, India, and went on to receive postgraduate training in internal medicine, pediatrics, cardiology, intensive coronary care, and anesthesiology. Prior to joining the pharmaceutical industry, he also earned a Master of Public Health from West Virginia University in Morgantown, West Virginia and served as a Surveillance Medical Officer working for the World Health Organization.